Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...

Novo's blockbuster diabetes drug Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ...